Structural Characterization of Inhibitor Complexes with Checkpoint Kinase 2 (Chk2), a Drug Target for Cancer Therapy.
Lountos, G.T., Jobson, A.G., Tropea, J.E., Self, C.R., Zhang, G., Pommier, Y., Shoemaker, R.H., Waugh, D.S.(2011) J Struct Biol 176: 292
- PubMed: 21963792 
- DOI: 10.1016/j.jsb.2011.09.008
- Primary Citation of Related Structures:  
2XK9, 2YCF, 2YCQ, 2YCR, 2YCS - PubMed Abstract: 
Chk2 (checkpoint kinase 2) is a serine/threonine kinase that participates in a series of signaling networks responsible for maintaining genomic integrity and responding to DNA damage. The development of selective Chk2 inhibitors has recently attracted much interest as a means of sensitizing cancer cells to current DNA-damaging agents used in the treatment of cancer ...